Phenotypic and immunohistochemical characterization of sarcoglycanopathies [PDF]
INTRODUCTION: Limb-girdle muscular dystrophy presents with heterogeneous clinical and molecular features. The primary characteristic of this disorder is proximal muscular weakness with variable age of onset, speed of progression, and intensity of ...
Ana F. B. Ferreira +5 more
doaj +6 more sources
Profiling of pathogenic variants in Japanese patients with sarcoglycanopathy [PDF]
Background Sarcoglycanopathies (SGPs) are limb-girdle muscular dystrophies (LGMDs) that can be classified into four types, LGMDR3, LGMDR4, LGMDR5, and LGMDR6, caused by mutations in the genes, SGCA, SGCB, SGCG, and SGCD, respectively. SGPs are relatively
Rui Shimazaki +12 more
doaj +4 more sources
Muscle Diversity, Heterogeneity, and Gradients: Learning from Sarcoglycanopathies [PDF]
Skeletal muscle, the most abundant tissue in the body, is heterogeneous. This heterogeneity forms the basis of muscle diversity, which is reflected in the specialized functions of muscles in different parts of the body. However, these different parts are
Marina Bouché +2 more
exaly +5 more sources
Muscle inflammatory pattern in alpha- and gamma-sarcoglycanopathies
Since the immune system plays a role in the pathogenesis of several muscular dystrophies, we aim to characterize several muscular inflammatory features in α- (LGMD R3) and γ-sarcoglycanopathies (LGMD R5).We explored the expression of major histocompatibility complex class I molecules (MHCI), and we analyzed the composition of the immune infiltrates in ...
Panicucci C. +11 more
core +9 more sources
Les sarcoglycanopathies font partie des dystrophies musculaires des ceintures (LGMD) autosomiques récessives et représentent la troisième cause la plus fréquente d’entre elles. Elles sont consécutives à un déficit d’un des sarcoglycanes α, β, γ, ou δ.
Gorka Fernández-Eulate +4 more
openaire +2 more sources
Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects [PDF]
Sarcoglycanopathies are a group of autosomal recessive muscle-wasting disorders caused by genetic defects in one of four cell membrane glycoproteins, α-, β-, γ- or δ-sarcoglycan. These four sarcoglycans form a subcomplex that is closely linked to the major dystrophin-associated protein complex, which is essential for membrane integrity during muscle ...
SANDONA', DORIANNA, BETTO R.
openaire +5 more sources
Sarcoglycanopathy with absent expression of all sarcoglycan proteins in a young cat with clinical features of feline hypertrophic muscular dystrophy [PDF]
Case summary A 1-year-old, male castrated domestic shorthair cat presented for chronic mobility decline and muscle stiffness, first noted at 3 months of age, and persistently elevated serum creatine kinase levels (>19,000–53,000 IU/l).
Arian Doroudi +2 more
doaj +2 more sources
Value of muscle magnetic resonance imaging in the differential diagnosis of muscular dystrophies related to the dystrophin-glycoprotein complex [PDF]
Background Dystrophin-glycoprotein complex (DGC)-related muscular dystrophies may present similar clinical and pathological features as well as undetectable mutations thus being sometimes difficult to distinguish.
Zhiying Xie +11 more
doaj +2 more sources
Sarcospan protects against LGMD R5 via remodeling of the sarcoglycan complex composition in dystrophic mice [PDF]
The dystrophin-glycoprotein complex (DGC) is composed of peripheral and integral membrane proteins at the muscle cell membrane that link the extracellular matrix with the intracellular cytoskeleton.
Ekaterina I. Mokhonova +14 more
doaj +2 more sources
MRI in sarcoglycanopathies: a large international cohort study [PDF]
ObjectivesTo characterise the pattern and spectrum of involvement on muscle MRI in a large cohort of patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C–2F) caused by mutations in one of the four genes coding for muscle sarcoglycans.MethodsLower limb MRI scans of patients with LGMD2C–2F, ranging from severe childhood ...
Tasca, Giorgio +34 more
core +11 more sources

